Granalix Bio Technologies

Granalix focuses on developing science-based novel formulations of natural antioxidants with increased bioavailability that target specific organs. Based in Israel, Granalix was established in 2014 by a group of scientists as a spinoff of the Yissum Research Development Company of the Hebrew University of Jerusalem, the technology-transfer company of the Hebrew University and Hadasit, the Technology Transfer Company of Hadassah Medical Organization. The company’s flagship product GranaGard is a submicron self-emulsion formulation of Pomegranate Seed Oil (PSO).